Replies to post #235364 on Biotech Values

[DewDiligence]

ALGS doses_first_HBV_patient_in_phase-1_trial_of ALG-010133—an_injected_oligo_directed_at_HBsAg:

https://finance.yahoo.com/news/aligos-therapeutics-begins-dosing-stops-130000865.html

ALGS is -4% today, but I doubt that the move has anything to do with the above PR.

[DewDiligence]

ALGS doses first cohort in ALG-000184 phase-1:

https://finance.yahoo.com/news/aligos-therapeutics-begins-dosing-capsid-120000588.html

Why did it take six months from the announcement of the trial start in Oct 2020 (#msg-159214118) to begin dosing? That’s not a good sign, IMO.